KIR3DL2 and Alzheimer disease: These results implied that the upregulation of KIR3DL2, PPP2R2B and QPCT and the downregulation of FRAT2, WWC3 and SPG20 in peripheral B cells can serve as a gene panel of biomarkers for the diagnosis and prognosis of AD.